ESTRO 2024 - Abstract Book

S1046

Clinical - Gynaecology

ESTRO 2024

Conclusion:

Gynaecological cancers and their treatments can cause toxicity in patients' quality of sexual life. However, this toxicity is poorly represented in the literature. For those aspects of sexual toxicity where the evidence is not definitive, expert panel consensus may help in clinical decision making. The authors consider sexual life a very important aspect of follow-up and specific recommendations are needed.

Keywords: Quality-of-life, sexual, health

References:

1. Bober SL, Reese JB, Barbera L, Bradford A, Carpenter KM, Goldfarb S, Carter J. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliat Care. 2016 Mar;10(1):44-54. doi: 10.1097/SPC.0000000000000186. PMID: 26716390; PMCID: PMC4984532. 2. Roussin M, Lowe J, Hamilton A, Martin L. Factors of sexual quality of life in gynaecological cancers: a systematic literature review. Arch Gynecol Obstet. 2021 Sep;304(3):791-805. doi: 10.1007/s00404-021-06056-0. Epub 2021 Apr 13. Erratum in: Arch Gynecol Obstet. 2021 May 27;: PMID: 33847794; PMCID: PMC8325662.